De-escalation Neoadjuvant Therapy for Intermediate Risk HER2-positive Early Breast
De-escalation Neoadjuvant Therapy for Intermediate Risk HER2-positive Early Breast
Not yet recruiting · NCT07748260 · Registry updated 2026-08-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| De-escalation Neoadjuvant Therapy for Intermediate Risk HER2-positive Early Breast | HER2-positive Breast Cancer | Not yet recruiting | Phase 3 | 2026-08-05 | NCT07748260 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Guangdong Provincial People's Hospital | 164 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||